UBS Group
EXAS

UBS Group’s Exact Sciences EXAS Stock Holding History

UBS Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,989,407
Closed -$304M – 10683
2025
Q4 		$304M Buy
2,989,407
+2,377,997
+389% +$191M 0.05% 379
2025
Q3 		$33.5M Buy
611,410
+146,964
+32% +$7.34M 0.01% 2030
2025
Q2 		$24.7M Sell
464,446
-789,231
-63% -$40.1M ﹤0.01% 2157
2025
Q1 		$54.3M Sell
1,253,677
-239,948
-16% -$12.2M 0.01% 1407
2024
Q4 		$83.9M Buy
1,493,625
+1,184,439
+383% +$73.7M 0.02% 1031
2024
Q3 		$21.1M Sell
309,186
-119,959
-28% -$6.77M ﹤0.01% 1782
2024
Q2 		$18.1M Buy
429,145
+167,214
+64% +$9.2M ﹤0.01% 1768
2024
Q1 		$18.1M Buy
261,931
+46,107
+21% +$2.92M ﹤0.01% 1785
2023
Q4 		$16M Sell
215,824
-7,685
-3% -$504K ﹤0.01% 1743
2023
Q3 		$15.2M Buy
223,509
+26,485
+13% +$2.25M 0.01% 1677
2023
Q2 		$18.5M Buy
197,024
+55,027
+39% +$4.29M 0.01% 1510
2023
Q1 		$9.63M Sell
141,997
-159,691
-53% -$10.3M ﹤0.01% 1916
2022
Q4 		$14.9M Buy
301,688
+143,542
+91% +$5.87M 0.01% 1628
2022
Q3 		$5.14M Sell
158,146
-15,514
-9% -$640K ﹤0.01% 2325
2022
Q2 		$6.84M Sell
173,660
-78,590
-31% -$4.2M ﹤0.01% 2108
2022
Q1 		$17.6M Sell
252,250
-85,247
-25% -$6.23M 0.01% 1523
2021
Q4 		$26.3M Buy
337,497
+36,430
+12% +$3.22M 0.01% 1396
2021
Q3 		$28.7M Buy
301,067
+90,949
+43% +$9.6M 0.01% 1218
2021
Q2 		$26.1M Sell
210,118
-59,715
-22% -$7.13M 0.01% 1288
2021
Q1 		$35.6M Buy
269,833
+19,719
+8% +$2.7M 0.01% 1047
2020
Q4 		$33.1M Sell
250,114
-19,009
-7% -$2.3M 0.01% 1026
2020
Q3 		$27.4M Sell
269,123
-20,854
-7% -$1.8M 0.01% 974
2020
Q2 		$25.2M Sell
289,977
-104,577
-27% -$8.36M 0.01% 957
2020
Q1 		$22.9M Buy
394,554
+105,077
+36% +$8.53M 0.01% 916
2019
Q4 		$26.8M Sell
289,477
-37,854
-12% -$3.33M 0.01% 1163
2019
Q3 		$29.9M Buy
327,331
+1,837
+0.6% +$209K 0.01% 976
2019
Q2 		$38.4M Buy
325,494
+77,920
+31% +$7.85M 0.01% 805
2019
Q1 		$21.4M Sell
247,574
-79,589
-24% -$6.77M 0.01% 1106
2018
Q4 		$20.6M Buy
327,163
+191,977
+142% +$13.2M 0.01% 1063
2018
Q3 		$10.7M Buy
135,186
+30,606
+29% +$2M ﹤0.01% 1730
2018
Q2 		$6.25M Sell
104,580
-91,467
-47% -$4.92M ﹤0.01% 2145
2018
Q1 		$7.91M Buy
196,047
+64,137
+49% +$3.13M ﹤0.01% 1902
2017
Q4 		$6.93M Sell
131,910
-45,354
-26% -$2.42M ﹤0.01% 2039
2017
Q3 		$8.35M Sell
177,264
-1,285,801
-88% -$51.8M ﹤0.01% 1755
2017
Q2 		$51.7M Buy
1,463,065
+1,354,760
+1,251% +$41.8M 0.03% 557
2017
Q1 		$2.56M Buy
108,305
+26,309
+32% +$521K ﹤0.01% 2709
2016
Q4 		$1.09M Sell
81,996
-108,680
-57% -$1.75M ﹤0.01% 3470
2016
Q3 		$3.54M Buy
190,676
+1,826
+1% +$32.2K ﹤0.01% 2342
2016
Q2 		$2.31M Sell
188,850
-34,592
-15% -$261K ﹤0.01% 2651
2016
Q1 		$1.51M Sell
223,442
-431,603
-66% -$2.76M ﹤0.01% 2914
2015
Q4 		$6.05M Buy
655,045
+522,642
+395% +$4.86M ﹤0.01% 1806
2015
Q3 		$2.38M Sell
132,403
-12,480
-9% -$287K ﹤0.01% 2572
2015
Q2 		$4.31M Sell
144,883
-14,513
-9% -$365K ﹤0.01% 2224
2015
Q1 		$3.51M Sell
159,396
-26,840
-14% -$681K ﹤0.01% 2393
2014
Q4 		$5.11M Buy
+186,236
New +$4.53M ﹤0.01% 2074

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

UBS Group's EXAS Position: Q1 2026 in Review

UBS Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,989,407 shares — an estimated $304M sold.

UBS Group first reported a position in EXAS in Q4 2014 and held it in 45 quarters. The position peaked at $304M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • UBS Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 2,989,407 Exact Sciences shares in Q1 2026, an estimated $304M.
  • UBS Group first reported a position in Exact Sciences in Q4 2014 and held it in 45 quarters.
  • UBS Group's Exact Sciences position peaked at $304M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.